Cell spheroids: the new frontiers in in vitro models for cancer drug validation

被引：95
|
作者：
Chatzinikolaidou, Maria [1 ]
机构：
[1] Univ Crete, Dept Mat Sci & Technol, POB 2208, Herakio 71003, Greece
来源：
DRUG DISCOVERY TODAY | 2016年 / 21卷 / 09期
关键词：
3-DIMENSIONAL TUMOR SPHEROIDS; ADVANCED SOLID MALIGNANCIES; MULTICELLULAR SPHEROIDS; BREAST-CANCER; PHASE-I; ANTICANCER THERAPEUTICS; CULTURE; MICROENVIRONMENT; VIVO; HETEROGENEITY;
D O I：
10.1016/j.drudis.2016.06.024
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
During the past decades, evaluation of anticancer drugs utilizing 2D cell cultures has been in common usage. In contrast to 2D cell cultures however, which lack many characteristics of the complex in vivo situation, 3D cell or tissue culture systems, such as cellular spheroids, better mimic the crucial tumor tissue properties and the microenvironment, and are thus more appropriate for the evaluation of pharmaceutical candidates. Taking the characteristics of the tumor microenvironment into consideration, crucial aspects and recent advances related to cell spheroids in the validation of anticancer drugs are discussed here.
引用
收藏
页码：1553 / 1560
页数：8
相关论文
共 50 条
  • [41] New Frontiers in Skin Cancer
    del Marmol, Veronique
    Stratigos, Alexander J.
    CURRENT OPINION IN ONCOLOGY, 2019, 31 (02) : 53 - 53
  • [42] New frontiers in cancer research
    Lewis, R
    Gallagher, R
    SCIENTIST, 2003, : 5 - 5
  • [43] The Cancer Moonshot, the role of in vitro models, model accuracy, and the need for validation
    Peter C. Searson
    Nature Nanotechnology, 2023, 18 : 1121 - 1123
  • [44] High affinity targeting of activated corneal keratocytes in vitro:: subtractive SELEX;: new frontiers for in vivo cell labelling and targeted drug delivery
    Angunawela, RI
    Bunka, DHJ
    Stockley, P
    Marshall, J
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46
  • [45] The Cancer Moonshot, the role of in vitro models, model accuracy, and the need for validation
    Searson, Peter C.
    NATURE NANOTECHNOLOGY, 2023, 18 (10) : 1121 - 1123
  • [46] New frontiers in cell competition†
    de Beco, Simon
    Ziosi, Marcello
    Johnston, Laura A.
    DEVELOPMENTAL DYNAMICS, 2012, 241 (05) : 831 - 841
  • [47] The role of murine models of prostate cancer in drug target discovery and validation
    Ahmad, Imran
    Sansom, Owen J.
    Leung, Hing Y.
    EXPERT OPINION ON DRUG DISCOVERY, 2009, 4 (08) : 879 - 888
  • [48] Anti-Cancer Drug Validation: the Contribution of Tissue Engineered Models
    Mariana R. Carvalho
    Daniela Lima
    Rui L. Reis
    Joaquim M. Oliveira
    Vitor M. Correlo
    Stem Cell Reviews and Reports, 2017, 13 : 347 - 363
  • [49] Anti-Cancer Drug Validation: the Contribution of Tissue Engineered Models
    Carvalho, Mariana R.
    Lima, Daniela
    Reis, Rui L.
    Oliveira, Joaquim M.
    Correlo, Vitor M.
    STEM CELL REVIEWS AND REPORTS, 2017, 13 (03) : 347 - 363
  • [50] In vitro Characterization of Insulin-Producing β-Cell Spheroids
    Ntamo, Yonela
    Samodien, Ebrahim
    Burger, Joleen
    Muller, Nolan
    Muller, Christo J. F.
    Chellan, Nireshni
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 8
12345